Caliper Life Sciences

Argenta Announces Collaboration with PainCeptor

Date Posted: Monday, May 01, 2006

Print Email to a friend

Argenta Discovery Ltd. has announced that it has entered into development collaboration with PainCeptor Pharma Corp.

Under the terms of the agreement, scientists from the two companies will exploit Argenta’s expertise in computer-aided drug design and medicinal chemistry to accelerate PainCeptor’s ASIC (acid-sensing ion channel) development programme for pain therapeutics, targeting these sensory mechanisms which are associated with a variety of pain-related conditions, including cancer and arthritis.
Commenting on the agreement, Dr Christopher Ashton, Argenta’s CEO, said, "We are delighted that PainCeptor has chosen to work with Argenta on this exciting programme."

"This is our first collaboration with the company and we believe their decision to work with Argenta is a tribute to the capabilities and expertise of our drug discovery team. We look forward to building a successful and long-term relationship with PainCeptor."
"We are pleased to be working with the Argenta team and believe their scientific expertise and experience will complement our own efforts and help us move our projects forward in the most expedient manner," added Dr. Francine Gervais, PainCeptor’s Senior Vice-President, Pharmaceutical Development.

Further Information:

Related news from our archive

Argenta Discovery Announces Contract Drug Discovery Collaboration with BioTie Therapies
Scientists from the two companies will exploit Argenta’s expertise in medicinal chemistry, computer-aided drug design and early ADME to advance one of BioTie’s therapeutics programmes.

Argenta Discovery Announces Second Two-Year Drug Discovery Collaboration with Genentech
Argenta to use its expertise in computer-aided drug design, medicinal chemistry and biology to discover new chemical entities acting against a second drug target defined by Genentech.

Argenta Announces Drug Discovery Collaboration with AstraZeneca
Argenta scientists will provide their expertise in medicinal chemistry to support drug discovery activities at AstraZeneca.

Argenta Implements Radleys’ StarFish™
Argenta has implemented the StarFish™ to improve the use of synthetic chemistry space.